First Page | Document Content | |
---|---|---|
Date: 2014-10-07 04:48:15Rare diseases Fabry disease Lysosomal storage disease Enzyme replacement therapy Genzyme Fabry Medical genetics Aspirin Medicine Health Lipid storage disorders | 06 radar report final 4_21.qxdAdd to Reading ListSource URL: www.fabry.orgDownload Document from Source WebsiteFile Size: 511,21 KBShare Document on Facebook |
Migalastat and Enzyme Replacement Therapy Have Comparable Effects on Renal Function in Fabry Disease: Phase 3 Study Results Nicholls, K1*, Bichet, DG2, Giugliani, R3, Hughes, D4, Schiffmann, R5, Wilcox, W6, Skuban, N7, RDocID: 1tiPw - View Document | |
United States Court of Appeals For the First Circuit NoANITA HOCHENDONER ET AL., Plaintiffs, Appellants, v.DocID: 1rtqA - View Document | |
www.edoriumjournals.com CASE SERIES PEER REVIEWED | OPEN ACCESSDocID: 1q86Q - View Document | |
The Journal of Rare Disorders CochraneCornerDocID: 19CDW - View Document | |
Study Group on Peripartum Cardiomyopathy Prof. K. Sliwa (Cape Town, South Africa) Prof. B. Pieske (Graz, AT) AimsDocID: 18N9y - View Document |